Advamab 400 Injection

Advamab 400mg Injection is an anticancer medication that contains Bevacizumab as its active ingredient. This treatment is designed to inhibit tumor growth. It is prescribed in conjunction with other chemotherapy drugs for the management of metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. Additionally, it is utilized for treating cancers of the ovary, fallopian tube, or primary peritoneal cancer. Effective birth control should be employed during treatment and for at least six months following the final dose. Advamab 400mg Injection is not advised for individuals under 18 years of age. If you are considering pregnancy soon, consult your doctor regarding ovarian preservation, as this medication may lead to fertility issues in women. It is also recommended to refrain from breastfeeding, as this drug may affect the growth and development of your baby.

Advamab 400mg Injection is frequently given alongside other chemotherapy medications. Common side effects include constipation, loss of appetite, runny nose, fever, skin issues, and weight loss. Prior to initiating treatment with this medication, inform your doctor if you have conditions such as high blood pressure, elevated blood sugar, gastrointestinal disorders, or heart issues. This medication should not be administered for 28 days before or after any surgical procedures due to its association with impaired wound healing and increased bleeding risks. It is important to notify your doctor of any dental problems requiring surgery before starting this treatment. Should you experience any changes in vision or confusion, contact your doctor immediately to avoid complications.